These compounds can mitigate tumor hypoxia, suppress P-glycoprotein (P-gp) expression, and synergistically interact with DOX to counteract multidrug resistance and ultimately enhance tumor therapy efficacy (Figure 7). The gene discussed is ABCB1; the disease is neoplasm.